T 1109/12 of 24.03.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T110912.20150324
- Date of decision
- 24 March 2015
- Case number
- T 1109/12
- Online on
- 29 May 2015
- Petition for review of
- -
- Application number
- 01998327.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION
- Applicant name
- Vectura Limited
- Opponent name
- NORTON HEALTHCARE LIMITED
AstraZeneca AB - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 84European Patent Convention Art 100(b)European Patent Convention Art 123(2)
- Keywords
- Amendments - added subject-matter (no)
Claims - clarity (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as amended in the following version:
- claims 1 to 20 of the main request filed with the grounds of appeal by letter of 23 July 2012;
- description, pages 2, 3, 4, 7 and 8 of the main request filed by letter of 3 March 2015 and pages 5, 6, 9, 10 and 11 of the patent specification;
- figures 1 to 6 of the patent specification.